Christopher Chipman
2023
In 2023, Christopher Chipman earned a total compensation of $491K as Former Chief Financial Officer at Virpax Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Option Awards | $75,000 |
|---|---|
| Salary | $169,000 |
| Other | $247,000 |
| Total | $491,000 |
Chipman received $247K in other compensation, accounting for 50% of the total pay in 2023.
Chipman also received $75K in option awards and $169K in salary.
Rankings
In 2023, Christopher Chipman's compensation ranked 2,044th out of 2,983 executives tracked by ExecPay. In other words, Chipman earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,044 out of 2,983 | 32nd |
Division Manufacturing | 1,161 out of 1,637 | 29th |
Major group Chemicals And Allied Products | 710 out of 906 | 22nd |
Industry group Drugs | 693 out of 869 | 20th |
Industry Pharmaceutical Preparations | 498 out of 627 | 21st |
Source: SEC filing on December 9, 2024.
Chipman's colleagues
We found four more compensation records of executives who worked with Christopher Chipman at Virpax Pharmaceuticals in 2023.